Digital Health Start-Up Audere Announces Its Partnership With Medical Diagnostech
Digital Health Start-Up Audere Announces Its Partnership With Medical Diagnostech. American digital health startup Audere has announced its partnership with South Africa’s Medical Diagnostech to provide Africa’s first home-grown Covid-19 antigen test and a digital companion app.
Audere’s HealthPulse digital companion app will enhance the end user experience, making testing easier and more accurate by providing digital administration instructions and unbiased result interpretation support powered by artificial intelligence. The solution will also improve public health reporting by digitizing the use of rapid tests and results, while seamlessly integrating with public health reporting systems. Access to aggregated test data will provide a comprehensive understanding of disease prevalence, enabling more informed surveillance and disease management.
Diagnostech, established in 2005, has been the sole distributor for Dako, an Agilent Technologies Company, in southern Africa for almost 2 decades, with its territory now including more than 34 African countries. Agilent Technologies Inc. acquired Dako in 2012, and through this acquisition, Diagnostech became the official sole distributor for Agilent Genomics and Diagnostic solutions, including Dako Pathology and Flow Cytometry Solutions in South Africa. The company has continued to grow and further expand its portfolio to include product offerings from HistoCyte Laboratories, LGC Biosearch Technologies, ArcherDx, Diagenode, 10x Genomics, LevitasBio, Milestone Medical and more.
Audere is a Seattle-based nonprofit that builds software to improve global health in the world’s most underserved communities. Its team of passionate, innovative minds combines smartphone technology, computer vision & machine learning, and the best of cloud-based services to deliver healthcare technology solutions worldwide.
